SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and ...
A renewed focus on the potentially transformative effect of cell and gene therapies (CGTs) will help businesses developing such treatments to attract investment and persuade policymakers to affect ...